Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

NCT00651482 is registered in ClinicalTrials.gov with Sandy Srinivas as lead sponsor.

NCT NCT00651482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00651482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
Lead sponsor
Sandy Srinivas
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2008
Completion date
March 31, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney (renal cell) cancer, kidney neoplasms